BioCardia, a leader in cardiovascular disease treatment, recently reported its Q4 2025 results, marking a significant ...

Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended December 31, ...

A made-in-Calgary 4D heart model is transforming treatment for heart failure patients having a specialized pacemaker inserted, called cardiac resynchronization therapy (CRT). In a clinical trial, ...

The heart is highly vital for keeping us alive because it moves blood around our bodies. Congestive Heart Failure (CHF) is a long-term, worsening condition in which the heart can't pump blood well ...

Cardiac patients who need life-saving surgical treatment can be heartened by the technological advances that let them live ...

Background The Swedish Targeted Health Dialogue (THD) is a widely implemented, individual-focused intervention involving screening and health counselling for mid-life individuals. Previous research ...

Pregnancy and childbirth are usually filled with anticipation and hope. Modern obstetrics has dramatically improved the ...

BioCardia ®, Inc. [NASDAQ: BCDA] , a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced the FDA has accepted its ...

Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to ...

Also, for the first time, doctors are advised to test for two biomarkers in the blood that have been linked to increased risks of heart disease.

Background Endovascular therapy (EVT) is standard treatment for large vessel occlusion in patients with a National Institutes ...

Geography once drove disparity, but access now hinges on how effectively centers can employ modern donor-utilization tools.